ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial americanpharmaceuticalreview
March 11, 2020Takeda Pharmaceutical announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO? (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients.
Pharma Sources Insight January 2025
